Who’s Hired? George and Yanai Join Amneal’s Board

Major Changes Also Made At Latvia’s Olainfarm

Two familiar industry figures have bolstered Amneal’s board, while Latvia’s Olanfarm has turned to a Sanofi executive for external expertise. Meanwhile, both Taro and Pfenex are recruiting CFOs.

People
Amneal has added considerable industry experience to its board • Source: Shutterstock

The former leaders of two of the world’s largest generics companies have joined the board of Amneal Pharmaceuticals. Ex-Sandoz divisional head and CEO Jeff George has become a director on the US firm’s board, as has former Teva CEO Shlomo Yanai.

George led Sandoz for more than five years between December 2008 and April 2014 before moving on to lead Novartis’s...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Leadership

More from Generics Bulletin